About Jean

Jean advises companies, investors and investment banks on a broad range of transactional and general corporate matters, including IPOs and other securities offerings, private investment in public equity (PIPE) transactions, private financings, and mergers and acquisitions. She also counsels late-stage private companies and public companies on the full spectrum of general corporate and securities laws matters.

View full bio

Experience

Inmagene Biopharmaceuticals Completes Merger With Ikena Oncology [UPDATED]

Inmagene Biopharmaceuticals Completes Merger With Ikena Oncology [UPDATED]

July 25, 2025

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Asa Henin
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Brittany K. Wightman
Associate, San Diego
Jiqiang Lin
Associate, New York
Leina Verrier
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Howard Morse
Senior Counsel, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jean Park
Partner, New York
Aaron Pomeroy
Partner, Colorado
Michelle Garcia Schulman
Partner, Reston
Ellie Seber
Partner, Santa Monica
Marty Schenker
Senior Counsel , San Francisco
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Rajdeep Roger Bains
Associate, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Adrienne Beaudoin Deshmukh
Associate, Reston
Jeremy M. Exelbert
Associate, New York
Zack Gong
Associate, Shanghai
Rick Jantz
Associate, Santa Monica
Wyatt Kernell
Associate, Colorado
Rebeca Kinslow
Associate, San Diego
Hilda Li
Associate, Hong Kong
Lunga Su
Associate, Shanghai
Novak Topalovic
Associate, San Diego
Tania Soris
Associate, New York
Monica Xu
Special Counsel, Shanghai
Sai Yarramalla
Associate, Palo Alto
Andy Zachrich
Associate, San Francisco
Patricia Myers
Paralegal Specialist, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Mergers and Acquisitions
Biotechnology
Healthcare
Capital Markets

Aardvark Therapeutics Announces $94.2 Million IPO

Aardvark Therapeutics Announces $94.2 Million IPO

February 14, 2025

Cooley advised the underwriters of Aardvark Therapeutics, a phase 3 biotech company developing novel small-molecule therapies for metabolic diseases, in connection with Aardvark’s $94.2 million initial public offering (IPO).

Read more

Related contacts

Charlie Kim
Partner, San Diego
Kristin VanderPas
Partner, San Francisco
Denny Won
Partner, San Francisco
Jean Park
Partner, New York
Christine Turner
Associate, Colorado
Ryan Lewis
Associate, Colorado
Joanna Zhang
Associate, San Diego
Lila Hope
Partner, Palo Alto
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Randy Sabett
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Zack Gong
Associate, Shanghai
Tony P. Guan
Associate, Santa Monica
Sarah Miller
Associate, New York

Related Practices & Industries

Capital Markets
Life Sciences
Healthcare
Biotechnology
Life Sciences and Healthcare Regulatory
Life Sciences Corporate Partnering and Licensing
Compensation and Benefits
Patent Counseling and Prosecution
Tax
Cyber/Data/Privacy
CFIUS

Inmagene Biopharmaceuticals Announces Merger With Ikena Oncology

Inmagene Biopharmaceuticals Announces Merger With Ikena Oncology

December 23, 2024

Cooley advised Inmagene Biopharmaceuticals, a privately held, global clinical-stage biotechnology company developing novel therapeutics for immunological and inflammatory diseases, on its definitive merger agreement with Ikena Oncology (Nasdaq: IKNA).

Read more

Related contacts

Lila Hope
Partner, Palo Alto
Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Asa Henin
Partner, San Diego
Lindsey O'Crump
Associate, Washington, DC
Brittany K. Wightman
Associate, San Diego
Jiqiang Lin
Associate, New York
Leina Verrier
Associate, Santa Monica
Ross Eberly
Partner, Santa Monica
Stephanie Gentile
Partner, New York
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Howard Morse
Senior Counsel, Washington, DC
Alessandra Murata
Partner, Palo Alto
Jean Park
Partner, New York
Aaron Pomeroy
Partner, Colorado
Michelle Garcia Schulman
Partner, Reston
Ellie Seber
Partner, Santa Monica
Marty Schenker
Senior Counsel , San Francisco
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Andrew Epstein
Special Counsel, Seattle
Stella Sarma
Partner, Brussels
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Robert Eisenbach
Of Counsel, San Francisco
Rajdeep Roger Bains
Associate, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Adrienne Beaudoin Deshmukh
Associate, Reston
Jeremy M. Exelbert
Associate, New York
Zack Gong
Associate, Shanghai
Rick Jantz
Associate, Santa Monica
Wyatt Kernell
Associate, Colorado
Rebeca Kinslow
Associate, San Diego
Hilda Li
Associate, Hong Kong
Lunga Su
Associate, Shanghai
Novak Topalovic
Associate, San Diego
Tania Soris
Associate, New York
Monica Xu
Special Counsel, Shanghai
Sai Yarramalla
Associate, Palo Alto
Andy Zachrich
Associate, San Francisco
Patricia Myers
Paralegal Specialist, Colorado
Jake Ironfield
Transactional Quantitative Analyst, New York

Related Practices & Industries

Mergers and Acquisitions
Life Sciences
Biotechnology
Healthcare

DEFCON AI Announces $44 Million Seed Financing

DEFCON AI Announces $44 Million Seed Financing

August 20, 2024

Cooley advised DEFCON AI, an insights company that’s building a next-generation modeling, simulation and analysis tool set for the modern military environment, on its $44 million in Seed financing.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Robert Warshaw
Associate, New York
David Fletcher
Partner, Washington, DC
Jim Fulton
Partner, New York
Charles Haley
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Jean Park
Partner, New York
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Ryan Montgomery
Partner, Boston
Grant Schweikert
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Ryan Guo
Associate, New York
Norris Kadet
Associate, New York
Katharina Schwarz
Associate, New York
Jill Simon
Senior Paralegal, New York
Katie Kissner
Quantitative Analyst, San Francisco
Brandon Lefebvre
Quantitative Analyst, Boston

Related Practices & Industries

National Security
Artificial Intelligence
CFIUS
Emerging Companies
Tax
Technology
Technology Transactions
Cyber/Data/Privacy
Capital Markets
Compensation and Benefits

Spring Health Announces $100 Million Series E

Spring Health Announces $100 Million Series E

July 31, 2024

Cooley advised Spring Health, the top global mental health solution for employers and health plans, on its $100 million Series E financing with a valuation of $3.3 billion.

Related contacts

Sacha Ross
Partner, New York
Robert Warshaw
Associate, New York
Michael Bruno
Associate, New York
Julie Paulino Montejo
Associate, New York
Jean Park
Partner, New York
Jon Avina
Partner, Palo Alto
Beth Sasfai
Partner, New York
Emma Bichet
Special Counsel, Brussels
Christopher Kimball
Partner, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Megan Browdie
Partner, Washington, DC
Jonathan Rivinus
Partner, Colorado

Related Practices & Industries

Emerging Companies
Digital Health
Healthcare
Commercial Litigation
ESG and Sustainability Advisory
CFIUS
Cyber/Data/Privacy
Antitrust and Competition
View more

Admissions and credentials

New York

California

Rankings and accolades

The Legal 500 US: Capital Markets: Equity Offerings (2025)

The Deal: Top Rising Star (2021)